Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W
Biology (Basel). 2025; 14(2).
PMID: 40001897
PMC: 11852324.
DOI: 10.3390/biology14020129.
Mocanu V, Lindquist S, Hjermind L, Heilmann J, MacLeod R, Lahiri N
Eur J Hum Genet. 2025; .
PMID: 39880983
DOI: 10.1038/s41431-025-01793-1.
Fahy N, Hayes O, Greaves C, Goldsmith S, Brotherhood E, Rohrer J
J Genet Couns. 2025; 34(1):e2000.
PMID: 39801084
PMC: 11725773.
DOI: 10.1002/jgc4.2000.
Howard J, Chaouch A, Douglas A, MacLeod R, Roggenbuck J, McNeill A
Eur J Hum Genet. 2024; 33(1):7-13.
PMID: 39501102
PMC: 11711763.
DOI: 10.1038/s41431-024-01718-4.
Cerecedo-Zapata C, Tapia-Guerrero Y, Ramirez-Gonzalez J, Meza-Dorantes A, Tercero-Perez K, Cortes H
Int J Mol Sci. 2024; 25(19.
PMID: 39409079
PMC: 11476844.
DOI: 10.3390/ijms251910750.
Predicting age of onset and progression of disease in late-onset genetic neurodegenerative diseases: An ethics review and research agenda.
Rensink M, Bolt I, Schermer M
Eur J Hum Genet. 2024; 32(11):1361-1370.
PMID: 39317749
PMC: 11576964.
DOI: 10.1038/s41431-024-01688-7.
[Psychiatric symptoms of Huntington's disease].
Muhlback A, Hoffmann R, Pozzi N, Marziniak M, Brieger P, Dose M
Nervenarzt. 2024; 95(9):871-884.
PMID: 39212681
PMC: 11374876.
DOI: 10.1007/s00115-024-01728-z.
Predictive genetic testing for Huntington's disease: Exploring participant experiences of uncertainty and ambivalence between clinic appointments.
Ballard L, Doheny S, Dimond R, Lucassen A, Clarke A
J Genet Couns. 2024; 34(1):e1911.
PMID: 38741209
PMC: 11735177.
DOI: 10.1002/jgc4.1911.
Clinical Review of Juvenile Huntington's Disease.
Oosterloo M, Touze A, Byrne L, Achenbach J, Aksoy H, Coleman A
J Huntingtons Dis. 2024; 13(2):149-161.
PMID: 38669553
PMC: 11307030.
DOI: 10.3233/JHD-231523.
Genetics in Parkinson's disease, state-of-the-art and future perspectives.
Trevisan L, Gaudio A, Monfrini E, Avanzino L, Di Fonzo A, Mandich P
Br Med Bull. 2024; 149(1):60-71.
PMID: 38282031
PMC: 10938543.
DOI: 10.1093/bmb/ldad035.
Genetic Testing in Parkinson's Disease.
Pal G, Cook L, Schulze J, Verbrugge J, Alcalay R, Merello M
Mov Disord. 2023; 38(8):1384-1396.
PMID: 37365908
PMC: 10946878.
DOI: 10.1002/mds.29500.
What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper.
Muhlbck A, van Walsem M, Nance M, Arnesen A, Page K, Fisher A
Orphanet J Rare Dis. 2023; 18(1):19.
PMID: 36717864
PMC: 9887752.
DOI: 10.1186/s13023-023-02622-8.
Psychosocial Impact of Huntington's Disease and Incentives to Improve Care for Affected Families in the Underserved Region of the Slovak Republic.
Hubcikova K, Rakus T, Muhlback A, Benetin J, Bruncvik L, Petrasova Z
J Pers Med. 2022; 12(12).
PMID: 36556162
PMC: 9783383.
DOI: 10.3390/jpm12121941.
Disclosure of Genetic Risk Factors for Alzheimer's Disease to Cognitively Healthy Individuals-From Current Practice towards a Personalised Medicine Scenario.
Galluzzi S, Pievani M, Zanetti O, Benussi L, The Italian-DIAfN Working Group , Frisoni G
Biomedicines. 2022; 10(12).
PMID: 36551936
PMC: 9775740.
DOI: 10.3390/biomedicines10123177.
Tools for communicating risk for Parkinson's disease.
Cook L, Schulze J, Uhlmann W, Verbrugge J, Marder K, Lee A
NPJ Parkinsons Dis. 2022; 8(1):164.
PMID: 36446806
PMC: 9709050.
DOI: 10.1038/s41531-022-00432-6.
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement.
Forloni G, Roiter I, Artuso V, Marcon M, Colesso W, Luban E
Prion. 2022; 16(1):66-77.
PMID: 35737759
PMC: 9235883.
DOI: 10.1080/19336896.2022.2083435.
Searching for Answers: Information-Seeking by Young People At-Risk for Huntington's Disease.
Chase C, Yashar B, Swope C, Albin R, Uhlmann W
J Huntingtons Dis. 2022; 11(3):337-346.
PMID: 35570496
PMC: 9484118.
DOI: 10.3233/JHD-210523.
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing.
Ketchum F, Chin N, Grill J, Gleason C, Erickson C, Clark L
Alzheimers Dement. 2022; 18(10):1969-1979.
PMID: 35213786
PMC: 9402800.
DOI: 10.1002/alz.12620.
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association.
Julio F, Blanco R, Casanova J, DAlessio B, De Schepper B, De Sousa D
J Pers Med. 2021; 11(8).
PMID: 34442459
PMC: 8400079.
DOI: 10.3390/jpm11080815.
Knowledge assessment and psychological impact of genetic counseling in people at risk for familial FTD.
Wong B, Lucente D, Krivensky S, Krahn E, Karlawish J, Dickerson B
Alzheimers Dement (Amst). 2021; 13(1):e12225.
PMID: 34337135
PMC: 8319661.
DOI: 10.1002/dad2.12225.
